Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-20-026691)

Filing Details

Accession Number:: 0000899243-20-026691
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-10-01 17:52:17
Reporting Period:: 2020-09-29

Accepted Time:: 2020-10-01 17:52:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1320350	Lensar Inc.	LNSR	Biological Products, (No Disgnostic Substances) (2836)	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
882104	Pdl Biopharma, Inc.	932 Southwood Boulevard Incline Village NV 89451		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-09-29	8,703	$11.16	8,667,397	No	4	P	Direct
Common Stock	Disposition	2020-10-01	8,667,397	$0.00	0	No	4	J	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	J	Direct

Footnotes

In connection with the separation of the Issuer from the Reporting Person on October 1, 2020, the Reporting Person distributed all of the shares of common stock of the Issuer in the form of a dividend to its stockholders.